Marta Maia Boscá-Watts

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

María Chaparro, A Garre, Francisco Mesonero et al. · Journal of Crohn s and Colitis · 2020 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer

Magdalena Esteva, Alfonso Leiva, María Ramos et al. · BMC Cancer · 2013 · 97 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

María Chaparro, A Garre, Marisa Iborra et al. · Journal of Crohn s and Colitis · 2021 · 81 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Factors predicting poor prognosis in ischemic colitis.

R Añón, Marta Maia Boscá-Watts, Vicente Sánchiz et al. · PubMed · 2006 · 69 citations · Full text

Medicine, Clinical Sciences, Surgery +14

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

María Chaparro, Iria Bastón‐Rey, E Fernández-Salgado et al. · Inflammatory Bowel Diseases · 2022 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14